mk2 Biotechnologies Overview
- Year Founded
-
2019
- Status
-
Acquired/Merged
- Employees
-
6
- Latest Deal Type
-
M&A
mk2 Biotechnologies General Information
Description
Developer of a peptide and protein purification technology designed to revolutionize recombinant production processes. The company's technology facilitates the production of enhanced-purity products, significantly diminishing the purification challenges prevalent in modern chemical and biological synthesis methods to meet specific requirements, enabling the pharmaceuticals, agriculture, and cosmetics industries to efficiently overcome purification and economy-to-scale obstacles encountered in stock breeding.
Contact Information
Website
www.mk2.bioCorporate Office
- Am Klopferspitz 19
- 82152 Planegg
- Germany
Corporate Office
- Am Klopferspitz 19
- 82152 Planegg
- Germany
mk2 Biotechnologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Merger/Acquisition | 03-Feb-2025 | Completed | Generating Revenue | |||
| 8. Early Stage VC | 12-Jul-2023 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | 01-Jun-2023 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 01-Feb-2023 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 01-Feb-2023 | Completed | Generating Revenue | |||
| 4. Seed Round | 29-Jul-2021 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Jan-2021 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 02-Jun-2020 | Completed | Generating Revenue | |||
| 1. Grant | 01-Jan-2019 | $3.42K | Completed | Generating Revenue |
mk2 Biotechnologies Patents
mk2 Biotechnologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025087483-A1 | Method of detecting peptides and/or proteins | Inactive | 24-Oct-2023 | ||
| JP-2025513487-A | Preparation of target peptides and proteins | Pending | 19-Apr-2022 | ||
| WO-2023203032-A1 | Preparation of target peptides and proteins | Inactive | 19-Apr-2022 | C07K14/79 |
mk2 Biotechnologies Signals
mk2 Biotechnologies Former Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Atlantis Ventures | Venture Capital | Minority | ||
| BioTools Innovator | Accelerator/Incubator | Minority | ||
| EIT Food | Accelerator/Incubator | Minority | ||
| Gateway Ventures | Venture Capital | Minority | ||
| German Accelerator | Accelerator/Incubator |
mk2 Biotechnologies FAQs
-
When was mk2 Biotechnologies founded?
mk2 Biotechnologies was founded in 2019.
-
Where is mk2 Biotechnologies headquartered?
mk2 Biotechnologies is headquartered in Planegg, Germany.
-
What is the size of mk2 Biotechnologies?
mk2 Biotechnologies has 6 total employees.
-
What industry is mk2 Biotechnologies in?
mk2 Biotechnologies’s primary industry is Biotechnology.
-
Is mk2 Biotechnologies a private or public company?
mk2 Biotechnologies is a Private company.
-
What is mk2 Biotechnologies’s current revenue?
The current revenue for mk2 Biotechnologies is .
-
Who are mk2 Biotechnologies’s investors?
Atlantis Ventures, BioTools Innovator, EIT Food, Gateway Ventures, and German Accelerator are 5 of 12 investors who have invested in mk2 Biotechnologies.
-
When was mk2 Biotechnologies acquired?
mk2 Biotechnologies was acquired on 03-Feb-2025.
-
Who acquired mk2 Biotechnologies?
mk2 Biotechnologies was acquired by Protevo Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process